Search Results - "Berton-Rigaud, Dominique"

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research.

Authors: Moniot, Aurélie Schneider, Christophe Chardin, Laure et al.

Source: Molecular Cancer. 8/14/2024, Vol. 23 Issue 1, p1-17. 17p.

"Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".

Authors: Gernier, François Ahmed-Lecheheb, Djihane Pautier, Patricia et al.

Source: BMC Cancer. 10/26/2021, Vol. 21 Issue 1, p1-12. 12p.

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.

Authors: King, Madeleine T. Stockler, Martin R. O’Connell, Rachel L. et al.

Source: Quality of Life Research. Jan2018, Vol. 27 Issue 1, p59-74. 16p.

Subjects: Ovarian cancer treatment, Ovarian cancer diagnosis, Cancer chemotherapy, Health surveys, Palliative treatment, Mental health, Quality of life, Cancer relapse, Comparative studies, Health status indicators, Longitudinal method, Research methodology, Medical cooperation, Ovarian tumors, Questionnaires, Research, Research evaluation, Research funding, Evaluation research

Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network.

Authors: Bonsang-Kitzis, Hélène Panchbhaya, Nabilah Bats, Anne-Sophie et al.

Source: Cancers. May2022, Vol. 14 Issue 9, pN.PAG-N.PAG. 13p.

Volume 22 Author Index.

Source: The oncologist Dec2017; Vol. 22 (12).

Journal Info: Publisher: Oxford University Press / USA ISSN: 1083-7159

NY-ESO-1-Specific Circulating CD4⁺ T Cells in Ovarian Cancer Patients Are Prevalently TH1 Type Cells Undetectable in the CD25⁺ FOXP3⁺ Treg Compartment.

Authors: Redjimi, Nassima Duperrier-Amouriaux, Karine Raimbaud, Isabelle et al.

Source: PLoS ONE. 2011, Vol. 6 Issue 7, p1-9. 9p.

Volume 18 Author Index.

Source: The oncologist Dec2013; Vol. 18 (12).

Journal Info: Publisher: Oxford University Press / USA ISSN: 1083-7159

Survival Benefit of Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer: A Multi-institutional Case Control Study.

Authors: Le Brun, Jean-François Campion, Loic Berton-Rigaud, Dominique et al.

Source: Annals of surgical oncology Oct2014; Vol. 21 (10).

Journal Info: Publisher: Springer Nature ISSN: 1068-9265